Endogenex, a clinical-stage medical technology company pioneering a new treatment for type 2 diabetes (T2D), today announced the closing of a $50 million extension of its Series C financing. Arboretum ...

Have an app you've always wanted to build? A humdrum task to automate? AI tools make it easier than ever, but they can be as ...

This study characterized the pharmacokinetics of nafamostat and its effect on post-filter and systemic Activated Clotting Time (ACT) across different membrane types in a porcine model of AKI receiving ...

Syncfusion Inc. today announced new benefits for Microsoft Visual Studio subscribers, expanding access to Syncfusion’s development tools for building modern applications and workflows.

Trent Frederic’s first collegiate goal, the Badgers’ fourth on the power play, was the final motion in a series of waves ...